What is the size of the Blood Product Market?
According to ÂÌñÉç internal database and industry insights, the Blood Product Market was exhibited at USD 51 billion in 2024 and is projected to reach USD 85 billion by 2031, growing at a CAGR of 7.4% during the forecast period 2025–2031.
This market is experiencing moderate growth in the coming years due to the increasing demand for blood transfusions, rising incidence of chronic diseases, and advancements in blood processing technologies.
Key Growth Factors of the Blood Product Market
- Increasing number of surgeries and trauma cases requiring blood transfusion
- Rising prevalence of blood-related disorders like anaemia and haemophilia
- Technological advancements in blood component separation and storage
- Expanding healthcare access and hospital infrastructure in developing regions
- Supportive government programs and blood donation awareness campaigns
Blood Product Market Trends
Blood product market is accelerating with notable trends such as the increasing shift towards component-based blood therapy, where blood is separated into red cells, plasma, platelets, and cryoprecipitate. Automation in blood processing and improved cold chain systems are becoming more common. Hospitals are also adopting RFID-based tracking for blood inventory and using predictive analytics for demand planning.
Emerging Developments in the Blood Product Market
Blood product market is seeing major developments which include progress in synthetic and lab-grown blood to address donor shortages. Alongside, there is reduction in the risk of contamination. 3D bioprinting of blood components is being researched for use in critical care and regenerative medicine. AI-driven systems for donor screening, automated cross-matching, and pathogen inactivation technologies are also improving safety and efficiency in blood product usage.
Leading Companies in the Blood Product Market
- Grifols S.A.
- CSL Behring
- Octapharma AG
- Takeda Pharmaceutical Company
- American Red Cross
- Sanquin
- Kedrion Biopharma
- Bio Products Laboratory
- Terumo BCT
- Haemonetics Corporation
How big is the Blood Product Market : FAQ's
The blood product market was exhibited at USD 51 billion in 2024 and is projected to reach USD 85 billion by 2031.
Increased surgical demand, chronic disease prevalence, and improved blood management technologies are driving the growth.
Component-based therapy, automation, RFID tracking, and predictive inventory tools are shaping the market.
Shortage of voluntary donors, high cost of processing, and risk of infectious transmission are the challenges faced by the market.
North America and Europe are leading the market and Asia-Pacific is also experiencing rapid growth.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com